Avaliação económica de ticagrelor em prevenção secundária pós Síndroma Coronária Aguda | Revista Portuguesa de Cardiologia (English edition)

Statistics

Artigo original

Avaliação económica de ticagrelor em prevenção secundária pós Síndroma Coronária Aguda

Economic evaluation of ticagrelor for secondary prevention following acute coronary syndromes

Miguel Gouveiaa, Margarida Borgesb, Rosário Trindadec,

, Klas Riknerd

a Católica Lisbon School of Business and Economics, Universidade Católica Portuguesa, Lisboa, Portugal

b Unidade de Farmacologia Clínica, Centro Hospitalar de Lisboa Central EPE & Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

c Corporate Affairs & Market Access Department, AstraZeneca ‐ Produtos Farmacêuticos, Lda., Lisboa, Portugal

d Global Clinical Development Department, AstraZeneca, Mölndal, Suécia

Read

11181

Times
was read the article

2767

Total PDF

8414

Total HTML

Share statistics

Article information

ISSN: 08702551
Original language: Portuguese

DOI:10.1016/j.repc.2014.08.004

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 8	89	47	136
2025 7	59	31	90
2025 6	59	23	82
2025 5	86	30	116
2025 4	90	28	118
2025 3	77	26	103
2025 2	74	16	90
2025 1	63	49	112
2024 12	56	28	84
2024 11	62	36	98
2024 10	50	32	82
2024 9	57	37	94
2024 8	50	31	81
2024 7	35	25	60
2024 6	41	18	59
2024 5	48	50	98
2024 4	46	55	101
2024 3	53	24	77
2024 2	30	22	52
2024 1	34	27	61
2023 12	33	24	57
2023 11	34	20	54
2023 10	38	19	57
2023 9	26	25	51
2023 8	44	23	67
2023 7	49	22	71
2023 6	42	24	66
2023 5	61	41	102
2023 4	60	23	83
2023 3	72	28	100
2023 2	64	15	79
2023 1	58	15	73
2022 12	101	25	126
2022 11	146	28	174
2022 10	93	18	111
2022 9	94	33	127
2022 8	63	43	106
2022 7	71	32	103
2022 6	56	26	82
2022 5	85	37	122
2022 4	70	28	98
2022 3	42	41	83
2022 2	64	22	86
2022 1	56	26	82
2021 12	37	31	68
2021 11	55	43	98
2021 10	55	48	103
2021 9	57	42	99
2021 8	55	40	95
2021 7	32	28	60
2021 6	40	38	78
2021 5	81	80	161
2021 4	125	16	141
2021 3	98	23	121
2021 2	106	14	120
2021 1	50	12	62
2020 12	52	19	71
2020 11	73	14	87
2020 10	76	13	89
2020 9	76	7	83
2020 8	50	11	61
2020 7	71	8	79
2020 6	53	8	61
2020 5	52	14	66
2020 4	61	11	72
2020 3	65	10	75
2020 2	179	38	217
2020 1	63	4	67
2019 12	51	12	63
2019 11	47	6	53
2019 10	43	7	50
2019 9	82	9	91
2019 8	34	7	41
2019 7	54	13	67
2019 6	59	8	67
2019 5	56	8	64
2019 4	39	17	56
2019 3	52	11	63
2019 2	36	13	49
2019 1	50	8	58
2018 12	50	14	64
2018 11	135	28	163
2018 10	363	20	383
2018 9	96	7	103
2018 8	99	14	113
2018 7	74	15	89
2018 6	123	15	138
2018 5	98	14	112
2018 4	80	16	96
2018 3	90	8	98
2018 2	69	5	74
2018 1	78	8	86
2017 12	64	14	78
2017 11	52	15	67
2017 10	62	26	88
2017 9	45	17	62
2017 8	41	15	56
2017 7	42	10	52
2017 6	45	14	59
2017 5	85	26	111
2017 4	28	15	43
2017 3	52	27	79
2017 2	85	24	109
2017 1	79	7	86
2016 12	43	13	56
2016 11	52	18	70
2016 10	58	18	76
2016 9	155	21	176
2016 8	25	15	40
2016 7	20	15	35
2016 6	2	19	21
2016 5	7	10	17
2016 4	40	9	49
2016 3	63	18	81
2016 2	78	19	97
2016 1	87	17	104
2015 12	58	14	72
2015 11	62	16	78
2015 10	65	13	78
2015 9	60	21	81
2015 8	60	23	83
2015 7	54	9	63
2015 6	55	7	62
2015 5	61	14	75
2015 4	82	19	101
2015 3	73	17	90
2015 2	144	69	213
2015 1	29	15	44

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter